Nov 12, 2025 08:06AM
Nov 12, 2025 07:30AM
Oct 24, 2025 04:26PM
Oct 24, 2025 04:25PM
Sep 9, 2025 08:41AM
Aug 20, 2025 08:30AM
Aug 20, 2025 08:30AM Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share
Aug 13, 2025 08:28AM
Aug 13, 2025 07:30AM
May 27, 2025 08:01AM
May 13, 2025 07:53AM
May 13, 2025 07:30AM
Mar 17, 2025 04:30PM
Nov 7, 2024 07:30AM XOMA Royalty Reports Third Quarter 2024 Financial Results and Highlights Recent Activities
Aug 13, 2024 07:37AM
Aug 13, 2024 07:30AM
May 9, 2024 08:19AM
May 9, 2024 07:30AM
Mar 8, 2024 07:30AM
Nov 7, 2023 08:03AM
Nov 7, 2023 07:30AM XOMA Reports Third Quarter 2023 Financial Results and Highlights Upcoming Events Expected to Drive Shareholder Value
Aug 8, 2023 07:56AM
Aug 8, 2023 07:30AM
May 9, 2023 07:44AM
May 9, 2023 07:30AM
Mar 9, 2023 07:30AM
Mar 9, 2023 07:30AM
Nov 3, 2022 07:30AM XOMA Reports Third Quarter 2022 Financial Results and Highlights Recent Operational Events
Aug 4, 2022 07:30AM
May 5, 2022 07:30AM
Mar 8, 2022 07:30AM
Nov 4, 2021 07:30AM
Aug 5, 2021 07:30AM
May 6, 2021 07:30AM
Mar 10, 2021 07:30AM XOMA Reports Fourth Quarter and Full-Year 2020 Financial Results and Operating Highlights
Nov 5, 2020 07:30AM
Aug 6, 2020 04:05PM
May 5, 2020 07:30AM
Mar 10, 2020 07:30AM
Nov 5, 2019 10:59AM
Nov 5, 2019 08:20AM
Aug 6, 2019 07:30AM XOMA Reports Second Quarter 2019 Royalty Asset Portfolio Highlights and Financial Results
May 6, 2019 04:30PM
Mar 7, 2019 07:19AM
Mar 7, 2019 07:05AM
Nov 7, 2018 07:20AM
Nov 7, 2018 07:00AM
Oct 18, 2018 03:19PM
Aug 7, 2018 04:35PM XOMA Reports Second Quarter 2018 Financial Results
May 9, 2018 04:07PM

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All